| payload |
{"created_at":"2026-04-18T15:49:14.474 {"created_at":"2026-04-18T15:49:14.474663+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/should-you-sell-adaptive-biotechnologies-adpt-after-its-president-and-coo-sold-57000","value":{"fp":"80580044120acc92","kind":"unusual_volume","published_at":"2026-04-18T14:57:38+00:00","source":"Nasdaq Markets","summary":"Key Points57,180 shares were sold for a total transaction value of approximately ~$826,000 across multiple days ending April 16, 2026.","tickers":["ADPT"],"title":"Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?","url":"https://www.nasdaq.com/articles/should-you-sell-adaptive-biotechnologies-adpt-after-its-president-and-coo-sold-57000"}}... |